Collaboration to develop and market vision analysis system

Article

Visiometrics and Medeuronet have formed together to develop and market Visiometrics' Optical Quality Analysis System (OQAS).

Visiometrics and Medeuronet have formed together to develop and market Visiometrics' Optical Quality Analysis System (OQAS).

Pan-European strategic commercial partner Medeuronet will market the system, created by Barcelona-based ophthalmic firm Visiometrics. OQAS is based on the works of Dr Pablo Artal, University of Murcia, Spain.

The system is based on the double-pass technique in which the punctual light source's size and shape projected onto the retina is analysed. The analysis will then provide the user with the point spread function (PSF), tear film quality, optical scattering index (OSI) and the modulation transfer function (MTF) of the eye.

Medeuronet aims to educate users on using the system in a clinical environment and how to make use of its benefits. The OQAS can be used to diagnose pathologies and compare pre and post-cataract and refractive surgery measurements and outcomes.

Other features of the OQAS include accommodation on retinal image quality, objective measurement of halos and glare and presenting the impact of higher-order aberrations and light scatter on visual acuity.

Visiometrics' Chief Executive Officer said, "We see this partnership with Medeuronet as a critical next step in the acceptance of OQAS on a wider commercial scale. We know that OQAS is the key tool to accurately and objectively assess the patient's quality of vision."

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.